Analyst Ratings for Rocket Pharmaceuticals (RCKT)
RCKT Rating Summary
RCKT Price Target Summary
- Highest: $15.00 (Cantor Fitzgerald)
- Lowest: $2.95 (Jefferies)
- Average: $8.49
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.49 (+289.6%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Avg. $ Target:
$8.49 (+289.6%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/8/2026 | Goldman Sachs | Richard Law | Upgrade | Neutral (Sell) |
4.00 (3.00) |
2.48 (2.18) |
-12.1% | Details |
| 9/16/2026 | Needham | Gil Blum | Upgrade | Buy (Hold) |
9.00 (N/A) |
3.41 (2.18) |
-36.07% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
